Metis Precision Medicine

Metis Precision Medicine is a B-Corp dedicated to providing powerful cancer treatment services for patients in need. Metis owns a set of intellectual property rights for anti-Met monoclonal antibodies (mAbs) with distinct and unique mechanisms of action.